Well Done, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Well Done, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 09, 2019	SELL	$372.08 - $439.57 $52,835 - $62,418	-142 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $47,686 - $57,231	142 New	142 $53,000
Q2 2018 Aug 03, 2018	SELL	$284.6 - $344.99 $15,653 - $18,974	-55 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$315.82 - $393.78 $17,370 - $21,657	55 New	55 $19,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Well Done, LLC, based on Form 13F filings with the SEC.

Stay updated on Well Done, LLC with notifications on news.